Industry / Singapore
New Angina Drug Reaches Market
August 2008 | Product LaunchFrench firm Servier has launched Coralan (ivabradine) in Singapore for the treatment of angina. Because of the city state's affluence and the increasing burden of cardiovascular disease, BMI expects the product to perform well, especially if the drug is approved for additional indications such as heart failure. However, revenue will be limited by Singapore's small population.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
